Name
Pae Loomakliinik OÜ
Registry code
11883340
VAT number
EE101346375
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
29.01.2010 (14)
Financial year
01.01-31.12
Capital
6 072.00 €
Activity
75001 - Veterinary activities 4776 - Retail sale of flowers, plants, seeds, fertilisers, pet animals and pet food in specialised stores
74 015 €
-150 €
-0%
482 €
(estimate is approximate)
52 248 €
2
Submitted
No tax arrears
-0%
-0%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Veiko Meus-Salk 29.06.1970 (54) | 100% - 6 072.00 EUR | Board member | Direct ownership | Founder |
| Kaja Riisenberg 09.04.1947 (77) | - | - | - | Auditor who has assessed non-monetary contribution |
| 2019 04.05.2020 | 2020 22.02.2021 | 2021 21.06.2022 | 2022 16.06.2023 | 2023 19.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 86 241 € | 85 686 € | 83 154 € | 80 704 € | 74 015 € |
| Net profit (loss) for the period | -1 823 € | 12 606 € | 7 062 € | 1 327 € | -150 € |
| Profit Margin | -2% | 15% | 8% | 2% | -0% |
| Current Assets | 20 095 € | 25 194 € | 28 723 € | 26 711 € | 28 374 € |
| Fixed Assets | 29 504 € | 23 554 € | 33 203 € | 35 985 € | 31 087 € |
| Total Assets | 49 599 € | 48 748 € | 61 926 € | 62 696 € | 59 461 € |
| Current Liabilities | 18 196 € | 4 740 € | 10 855 € | 10 301 € | 7 213 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 31 403 € | 44 008 € | 51 071 € | 52 395 € | 52 248 € |
| Employees | 3 | 3 | 2 | 2 | 2 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 14 348.8 € | 2 226.3 € | 1 593.86 € | 2 |
| 2023 Q4 | 18 118.13 € | 2 881.88 € | 1 688.52 € | 2 |
| 2023 Q3 | 18 615.83 € | 2 962.03 € | 1 475.39 € | 2 |
| 2023 Q2 | 21 712.09 € | 3 431.98 € | 1 658 € | 2 |
| 2023 Q1 | 17 672.55 € | 2 105.19 € | 1 393.31 € | 3 |
| 2022 Q4 | 19 754.6 € | 2 227.29 € | 1 219.88 € | 2 |
| 2022 Q3 | 21 187.98 € | 3 064.09 € | 1 555.3 € | 2 |
| 2022 Q2 | 22 357.94 € | 2 211.76 € | 1 481.17 € | 2 |
| 2022 Q1 | 18 519.64 € | 2 390.74 € | 1 636.34 € | 2 |
| 2021 Q4 | 18 171.17 € | 2 753.61 € | 1 630.02 € | 2 |
| 2021 Q3 | 21 603.91 € | 3 086.04 € | 1 191.98 € | 3 |
| 2021 Q2 | 24 425.6 € | 2 446.77 € | 913.75 € | 3 |
| 2021 Q1 | 19 751.94 € | 2 108.93 € | 968.83 € | 3 |
| 2020 Q4 | 18 550.2 € | 2 043.18 € | 777.44 € | 3 |
| 2020 Q3 | 20 569.09 € | 2 624.77 € | 1 073.32 € | 3 |
| 2020 Q2 | 23 338.88 € | 2 699.93 € | 884.26 € | 3 |
| 2020 Q1 | 24 489.09 € | 2 136.32 € | 895.3 € | 3 |
